Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit J Arsenault

Showing results (51-60 of 159) with videos related to

Pageof 16
Sort By:
Iscience|September 12, 2022
Genetic association and Mendelian randomization for hypothyroidism highlight immune molecular mechanismsSamuel Mathieu, Mewen Briend, Erik Abner, et al.
Communications Biology|May 3, 2020
Single-cell expression and Mendelian randomization analyses identify blood genes associated with lifespan and chronic diseasesArnaud Chignon, Valentin Bon-Baret, Marie-Chloé Boulanger, et al.
Circulation. Genomic and Precision Medicine|February 24, 2021
System Genetics Including Causal Inference Identify Immune Targets for Coronary Artery Disease and the LifespanValentin Bon-Baret, Arnaud Chignon, Marie-Chloé Boulanger, et al.
Atherosclerosis|December 22, 2016
Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population studyNicolas Perrot, Rutger Verbeek, Manjinder Sandhu, et al.
Journal of the American Heart Association|August 14, 2019
apoB/apoA-I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC-Norfolk Prospective Population StudyKang H Zheng, Benoit J Arsenault, Yannick Kaiser, et al.
Nutrients|December 28, 2021
Blood Levels of the <i>SMOC1</i> Hepatokine Are Not Causally Linked with Type 2 Diabetes: A Bidirectional Mendelian Randomization StudyNooshin Ghodsian, Eloi Gagnon, Jérôme Bourgault, et al.
Diabetes, Obesity & Metabolism|March 25, 2018
Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: A 1-year randomized studyMarie-Eve Piché, Anne-Sophie Laberge, Patrice Brassard, et al.
The American Journal of Cardiology|June 23, 2016
Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (from the Treating to New Targets [TNT] Study)Benoit J Arsenault, Payal Kohli, Gilles Lambert, et al.
Journal of the American College of Cardiology|April 4, 2015
Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trialYoung Sup Byun, Jun-Hee Lee, Benoit J Arsenault, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 19, 2016
Carriers of the PCSK9 R46L Variant Are Characterized by an Antiatherogenic Lipoprotein Profile Assessed by Nuclear Magnetic Resonance Spectroscopy-Brief ReportRutger Verbeek, Marjorie Boyer, S Matthijs Boekholdt, et al.
Pageof 16

Showing results (51-60 of 159) with videos related to

Sort By:
Pageof 16
Iscience|September 12, 2022
Genetic association and Mendelian randomization for hypothyroidism highlight immune molecular mechanismsSamuel Mathieu, Mewen Briend, Erik Abner, et al.
Communications Biology|May 3, 2020
Single-cell expression and Mendelian randomization analyses identify blood genes associated with lifespan and chronic diseasesArnaud Chignon, Valentin Bon-Baret, Marie-Chloé Boulanger, et al.
Circulation. Genomic and Precision Medicine|February 24, 2021
System Genetics Including Causal Inference Identify Immune Targets for Coronary Artery Disease and the LifespanValentin Bon-Baret, Arnaud Chignon, Marie-Chloé Boulanger, et al.
Atherosclerosis|December 22, 2016
Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population studyNicolas Perrot, Rutger Verbeek, Manjinder Sandhu, et al.
Journal of the American Heart Association|August 14, 2019
apoB/apoA-I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC-Norfolk Prospective Population StudyKang H Zheng, Benoit J Arsenault, Yannick Kaiser, et al.
Nutrients|December 28, 2021
Blood Levels of the <i>SMOC1</i> Hepatokine Are Not Causally Linked with Type 2 Diabetes: A Bidirectional Mendelian Randomization StudyNooshin Ghodsian, Eloi Gagnon, Jérôme Bourgault, et al.
Diabetes, Obesity & Metabolism|March 25, 2018
Rosiglitazone lowers resting and blood pressure response to exercise in men with type 2 diabetes: A 1-year randomized studyMarie-Eve Piché, Anne-Sophie Laberge, Patrice Brassard, et al.
The American Journal of Cardiology|June 23, 2016
Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (from the Treating to New Targets [TNT] Study)Benoit J Arsenault, Payal Kohli, Gilles Lambert, et al.
Journal of the American College of Cardiology|April 4, 2015
Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trialYoung Sup Byun, Jun-Hee Lee, Benoit J Arsenault, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 19, 2016
Carriers of the PCSK9 R46L Variant Are Characterized by an Antiatherogenic Lipoprotein Profile Assessed by Nuclear Magnetic Resonance Spectroscopy-Brief ReportRutger Verbeek, Marjorie Boyer, S Matthijs Boekholdt, et al.
Pageof 16